Skip to content

Clinical trials

Terminated Phase 1/2 Glioma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 1/2 Status: Terminated Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20112
20121
20132
20151
20162
20171
20181
20212
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation2
Alaunos Therapeutics1
Aminex Therapeutics, Inc.1
Bristol-Myers Squibb1
Children's Hospital Medical Center, Cincinnati1
Dawonmedax Co., Ltd.1
Eben Rosenthal1
Gilead Sciences1
Institut Curie1
M.D. Anderson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma18
Glioblastoma9
Astrocytoma5
Brain Neoplasms5
Diffuse Intrinsic Pontine Glioma5
Neoplasms3
Oligodendroglioma3
Recurrence3
Medulloblastoma2
Melanoma2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.